Cargando…
Hospital-acquired invasive pulmonary aspergillosis in patients with hepatic failure
BACKGROUND: Invasive pulmonary aspergillosis (IPA) is a rapid, progressive, fatal disease that occurs mostly in immunocompromised patients. Patients with severe liver disease are at a heightened risk for infections. Little is known about the clinical presentation including predisposing factors and t...
Autores principales: | Li, Dan, Chen, Liang, Ding, Xian, Tao, Ran, Zhang, Yong Xin, Wang, Jie Fei |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516516/ https://www.ncbi.nlm.nih.gov/pubmed/18667083 http://dx.doi.org/10.1186/1471-230X-8-32 |
Ejemplares similares
-
Invasive Pulmonary Aspergillosis
por: Ledoux, Marie-Pierre, et al.
Publicado: (2023) -
Invasive Pulmonary Aspergillosis in Acute-on-Chronic Liver Failure Patients: Short-Term Outcomes and Antifungal Options
por: Chen, Danli, et al.
Publicado: (2021) -
Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis
por: Persichino, Jon G., et al.
Publicado: (2018) -
Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis
por: Gao, Jie, et al.
Publicado: (2018) -
Differences in Clinical Characteristics of Invasive Tracheobronchial Aspergillosis according to the Presence of Invasive Pulmonary Aspergillosis
por: Pak, Chuiyong, et al.
Publicado: (2021)